Intermolecular Complementation between Two Varicella-Zoster Virus pORF30 Terminase Domains Essential for DNA Encapsidation.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26202238)

Published in J Virol on July 22, 2015

Authors

Melissa A Visalli1, Brittany L House1, Frances J Lahrman2, Robert J Visalli3

Author Affiliations

1: Department of Biomedical Sciences, Mercer University School of Medicine, Savannah, Georgia, USA.
2: Department of Biology, Indiana University-Purdue University Fort Wayne, Fort Wayne, Indiana, USA.
3: Department of Biomedical Sciences, Mercer University School of Medicine, Savannah, Georgia, USA visalli_rj@mercer.edu.

Articles cited by this

The Protein Data Bank. Nucleic Acids Res (2000) 187.10

Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc (2009) 32.64

Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol (2011) 28.61

Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res (2005) 11.23

The bacteriophage DNA packaging motor. Annu Rev Genet (2008) 3.25

Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation. N Engl J Med (2014) 3.12

Inhibition of human cytomegalovirus DNA maturation by a benzimidazole ribonucleoside is mediated through the UL89 gene product. J Virol (1998) 2.53

Herpes simplex virus type 1 DNA cleavage and encapsidation require the product of the UL28 gene: isolation and characterization of two UL28 deletion mutants. J Virol (1993) 2.44

Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56. J Virol (1998) 2.41

Herpes simplex virus DNA cleavage and packaging proteins associate with the procapsid prior to its maturation. J Virol (2001) 2.21

Herpes simplex virus type 1 UL28 gene product is important for the formation of mature capsids. J Gen Virol (1990) 2.15

Herpes simplex virus type 1 cleavage and packaging proteins UL15 and UL28 are associated with B but not C capsids during packaging. J Virol (1998) 1.91

The gene product of human cytomegalovirus open reading frame UL56 binds the pac motif and has specific nuclease activity. J Virol (1998) 1.73

Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management. Antimicrob Agents Chemother (2010) 1.73

Genetic analysis of the UL 15 gene locus for the putative terminase of herpes simplex virus type 1. Virology (1998) 1.66

Characterization of ICP6::lacZ insertion mutants of the UL15 gene of herpes simplex virus type 1 reveals the translation of two proteins. J Virol (1997) 1.60

The terminase subunits pUL56 and pUL89 of human cytomegalovirus are DNA-metabolizing proteins with toroidal structure. Nucleic Acids Res (2002) 1.54

DNA cleavage and packaging proteins encoded by genes U(L)28, U(L)15, and U(L)33 of herpes simplex virus type 1 form a complex in infected cells. J Virol (2002) 1.51

Physical and functional interactions between the herpes simplex virus UL15 and UL28 DNA cleavage and packaging proteins. J Virol (1999) 1.46

Herpes simplex virus type 1 portal protein UL6 interacts with the putative terminase subunits UL15 and UL28. J Virol (2003) 1.37

In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246. Antimicrob Agents Chemother (2010) 1.36

Novel class of thiourea compounds that inhibit herpes simplex virus type 1 DNA cleavage and encapsidation: resistance maps to the UL6 gene. J Virol (2000) 1.30

The putative terminase subunit of herpes simplex virus 1 encoded by UL28 is necessary and sufficient to mediate interaction between pUL15 and pUL33. J Virol (2006) 1.29

Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system. J Virol (2007) 1.29

Identification of the gene product encoded by ORF UL56 of the human cytomegalovirus genome. Virology (1993) 1.28

The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase. J Virol (2011) 1.25

Structural flexibility in human topoisomerase I revealed in multiple non-isomorphous crystal structures. J Mol Biol (1999) 1.24

Putative terminase subunits of herpes simplex virus 1 form a complex in the cytoplasm and interact with portal protein in the nucleus. J Virol (2007) 1.24

The bacteriophage DNA packaging machine. Adv Exp Med Biol (2012) 1.23

First report of successful treatment of multidrug-resistant cytomegalovirus disease with the novel anti-CMV compound AIC246. Am J Transplant (2011) 1.22

Identification of the ATP-binding site in the terminase subunit pUL56 of human cytomegalovirus. Nucleic Acids Res (2003) 1.19

Herpes simplex virus 1 DNA packaging proteins encoded by UL6, UL15, UL17, UL28, and UL33 are located on the external surface of the viral capsid. J Virol (2006) 1.18

Linker insertion mutations in the herpes simplex virus type 1 UL28 gene: effects on UL28 interaction with UL15 and UL33 and identification of a second-site mutation in the UL15 gene that suppresses a lethal UL28 mutation. J Virol (2006) 1.16

Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): in vitro and in vivo antiviral activity and mechanism of action. J Antimicrob Chemother (2001) 1.14

The human cytomegalovirus UL51 protein is essential for viral genome cleavage-packaging and interacts with the terminase subunits pUL56 and pUL89. J Virol (2012) 1.08

The potential terminase subunit of human cytomegalovirus, pUL56, is translocated into the nucleus by its own nuclear localization signal and interacts with importin alpha. J Gen Virol (2000) 1.07

Resolution of genotypic and phenotypic properties of herpes simplex virus type 1 temperature-sensitive mutant (KOS) tsZ47: evidence for allelic complementation in the UL28 gene. Virology (1993) 1.05

Herpes simplex virus 1 DNA cleavage/packaging: the UL28 gene encodes a minor component of B capsids. Virology (1998) 1.03

Identification of small molecule compounds that selectively inhibit varicella-zoster virus replication. J Virol (2003) 1.03

Quantification of the DNA cleavage and packaging proteins U(L)15 and U(L)28 in A and B capsids of herpes simplex virus type 1. J Virol (2004) 1.00

DNA encapsidation as a target for anti-herpesvirus drug therapy. Antiviral Res (2003) 1.00

The structure of the herpes simplex virus DNA-packaging terminase pUL15 nuclease domain suggests an evolutionary lineage among eukaryotic and prokaryotic viruses. J Virol (2013) 0.99

Identification of acetylated, tetrahalogenated benzimidazole D-ribonucleosides with enhanced activity against human cytomegalovirus. J Virol (2007) 0.98

Absence or overexpression of the Varicella-Zoster Virus (VZV) ORF29 latency-associated protein impairs late gene expression and reduces VZV latency in a rodent model. J Virol (2006) 0.97

Protein concerted motions in the DNA-human topoisomerase I complex. Nucleic Acids Res (2003) 0.97

Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. Antivir Ther (2008) 0.97

The DNA cleavage and packaging protein encoded by the UL33 gene of herpes simplex virus 1 associates with capsids. Virology (2004) 0.96

Mutagenesis of varicella-zoster virus glycoprotein B: putative fusion loop residues are essential for viral replication, and the furin cleavage motif contributes to pathogenesis in skin tissue in vivo. J Virol (2009) 0.96

Identification of the interaction domain of the small terminase subunit pUL89 with the large subunit pUL56 of human cytomegalovirus. Biochemistry (2006) 0.94

Antiviral drug resistance in herpesviruses other than cytomegalovirus. Rev Med Virol (2014) 0.93

Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study. Transpl Int (2014) 0.92

Role of a mutation in human cytomegalovirus gene UL104 in resistance to benzimidazole ribonucleosides. J Virol (2004) 0.90

Resistance of human cytomegalovirus to ganciclovir/valganciclovir: a comprehensive review of putative resistance pathways. Antiviral Res (2013) 0.89

The UL15 protein of herpes simplex virus type 1 is necessary for the localization of the UL28 and UL33 proteins to viral DNA replication centres. J Gen Virol (2008) 0.88

Changes in subcellular localization reveal interactions between human cytomegalovirus terminase subunits. Virol J (2012) 0.88

Mutational analysis of the herpes simplex virus type 1 DNA packaging protein UL33. J Virol (2009) 0.87

The Varicella-zoster virus DNA encapsidation genes: Identification and characterization of the putative terminase subunits. Virus Res (2007) 0.87

Varicella zoster virus ORF25 gene product: an essential hub protein linking encapsidation proteins and the nuclear egress complex. J Proteome Res (2011) 0.84

Letermovir Treatment of Human Cytomegalovirus Infection Antiinfective Agent. Drugs Future (2013) 0.83

Targeting of the gene product encoded by ORF UL56 of human cytomegalovirus into viral replication centers. FEBS Lett (2000) 0.83

Isolation and characterization of the herpes simplex virus 1 terminase complex. J Virol (2013) 0.81

Characterization of the Varicella-zoster virus ORF25 gene product: pORF25 interacts with multiple DNA encapsidation proteins. Virus Res (2009) 0.81

Current and Potential Treatments for Ubiquitous but Neglected Herpesvirus Infections. Chem Rev (2014) 0.80

Epstein-Barr virus BALF3 has nuclease activity and mediates mature virion production during the lytic cycle. J Virol (2014) 0.79

Ganciclovir-resistant human herpesvirus-6 encephalitis in a liver transplant patient: a case report. J Neurovirol (2011) 0.79

Testing the susceptibility of human herpesviruses to antivirals. Future Microbiol (2009) 0.77

Role of the UL28 homologue of bovine herpesvirus 1 in viral DNA cleavage and packaging. Arch Virol (2003) 0.76

The varicella-zoster virus portal protein is essential for cleavage and packaging of viral DNA. J Virol (2014) 0.76